Table 2.

Change from baseline in haemoglobin A1c (HbA1c) levels, liver MRI proton density fat fraction (MRI-PDFF) and weight (sham-treated modified intention-to-treat population)

Parameter	Europe N=37	Brazil N=16
HbA1c levels at 24 weeks, mmol/mol	n=33	n=15
	−3.3 (10.9)	−17.5 (9.8)
Liver MRI-PDFF >5% at baseline, n (%)	28 (75.7)	14 (87.5)
Absolute change in liver MRI-PDFF at 12 weeks, %	−2.2 (4.3)	−6.1 (7.8)
Weight at 24 weeks, kg	n=34	n=15
	−1.4 (2.4)	−2.1 (5.7)

Data are presented as median (IQR), unless otherwise indicated.